The UK is anticipated to acquire a total of 40 million doses by the finish of 2021, adequate to vaccinate up to a third of the population, with the majority of doses anticipated in the very first half of subsequent year.
“If approval is granted, the NHS (National Health Service) will be ready to deliver. The NHS has vast experience in delivering widespread vaccination programmes and an enormous amount of work has taken place to ensure we have the logistical expertise, transport and workforce to roll out a vaccine according to clinical priority, at the speed at which it can be manufactured,” UK Health Secretary Matt Hancock had stated final month.
The UK government stressed that the COVID-19 vaccine will only be authorised for provide by the UK’s independent regulator if it meets strict requirements of good quality, security, and effectiveness, and if they are happy the vaccine can be regularly manufactured.
The MHRA is the UK’s independent regulator, hailed as a globally recognised institution for requiring the highest requirements for good quality, security and effectiveness. The vaccine will be manufactured in BioNTech’s German web sites, as properly as Pfizer’s manufacturing website in Belgium.
The UK government stated it remains confident that the cold provide chain necessary to distribute the Pfizer/BioNTech vaccine will not result in any issues or delays. When the vaccine is stored in a fridge, it has an powerful life of up to 5 days at temperatures of 2 to 8 degrees, which will let it to be conveniently stored at distribution centres.